Russman highlights asundexian’s efficacy in patients following a non-cardioembolic ischemic stroke or high-risk transient ischemic attack.
Andrew Russman, DO
Advertisement
Andrew Russman, DO, is a neurologist and the section head of stroke and vascular neurology at the Cleveland Clinic.
Articles by Andrew Russman, DO
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Interstitial Lung Abnormalities: Recognition, Risk Stratification, and When to Act
2
Q&A: Intensive LDL Lowering and Cardiovascular Prevention Strategies, With Lawrence Leiter, MD
3
Management Strategies for Hypercortisolism
4
Evaluating Clinical and Real-World Evidence in Hypercortisolism
5